Industry Research Reports

Home > Reports > Chemical & Material > Global Hirudin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Global Hirudin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Industry: Chemical & Material

Published Date: 2025-03-28

Pages: 139 Pages

Report ld: 4671625

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Hirudin Market Size(US$)

CAGR 2025-2031

3.1%

Market Size,2031

USD 5,214

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 4,341 million

Market Forecast in 2031(Value)

US$ 5,214 million

CAGR

3.1%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

In 2024, the global market size of Hirudin was estimated to be worth US$ 4223 million and is forecast to reach approximately US$ 5214 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.

This report studies the Hirudin market. Hirudin is a naturally occurring peptide in the salivary glands of medicinal leeches (such as Hirudo medicinalis) that has a blood anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin. Hirudin (hirudin) is a Leech (Leech) and salivary glands have been extracted from a variety of active ingredients in the activity of the most significant and most studied ingredients, which is 65-66 amino acids from the small molecules of protein (peptide) . Hirudin have strong inhibitory effect on thrombin is the strongest so far found in the natural specific inhibitor of thrombin. Animal experiments and clinical studies have shown that hirudin can be effective anticoagulant, antithrombotic, and prevent thrombin-catalyzed activation of coagulation factors and platelet reactions and blood stasis phenomenon further. In addition, it also inhibited thrombin-induced fibroblast proliferation, and thrombin stimulation of endothelial cells. Compared with heparin, which not only use less, do not cause bleeding, is not dependent on endogenous cofactor; and heparin have caused the risk of bleeding, disseminated intravascular coagulation in the pathogenesis of antithrombin III are reduced This will limit the efficacy of heparin, using leeches will have good results.

Global Hirudin key players include Pfizer, Teva Pharmaceutical, The Medicines Company, SALUBRIS, DUOPUTAI, etc. Global top five manufacturers hold a share about 20%. North America is the largest market, with a share about 30%, followed by Europe, with a share about 20 percent. In terms of product, Natural Hirudin is the largest segment, with a share about 55%. And in terms of application, the largest application is Thrombosis Disease, followed by Tumor Disease, etc.

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Hirudin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hirudin.

The Hirudin market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hirudin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Hirudin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

By Company

The Medicines Company

Keyken

Minapharm

Abbott

SALUBRIS

Pfizer, Inc

Teva Pharmaceutical Industries Ltd

DUOPUTAI

Pentapharm

Segment by Type

Natural Hirudin

Recombinant Hirudin

Segment by Application

Thrombosis Disease

Tumor Disease

Others

By Region

North America

United States

Canada

Asia-Pacific

China

Japan

South Korea

India

Southeast Asia

Australia

Rest of Asia-Pacific

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Rest of Europe

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales (consumption), revenue of Hirudin in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 3: Detailed analysis of Hirudin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hirudin sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.

Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.

Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.

Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.

Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.

Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.

Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.

Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 14: Research Findings and Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Study Coverage

1.1 Hirudin Product Introduction

1.2 Market by Type

1.2.1 Global Hirudin Market Size Growth Rate by Type (2020 VS 2024 VS 2031)

1.2.2 Natural Hirudin

1.2.3 Recombinant Hirudin

1.3 Market by Application

1.3.1 Global Hirudin Market Size Growth Rate by Application (2020 VS 2024 VS 2031)

1.3.2 Thrombosis Disease

1.3.3 Tumor Disease

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Hirudin Market Size Estimates and Forecasts

2.1.1 Global Hirudin Revenue 2020-2031

2.1.2 Global Hirudin Sales 2020-2031

2.2 Hirudin Market Size by Region: 2024 Versus 2031

2.3 Hirudin Sales by Region (2020-2031)

2.3.1 Global Hirudin Sales by Region: 2020-2025

2.3.2 Global Hirudin Sales Forecast by Region (2026-2031)

2.3.3 Global Hirudin Sales Market Share by Region (2020-2031)

2.4 Hirudin Market Estimates and Projections by Region (2026-2031)

2.4.1 Global Hirudin Revenue by Region: 2020-2025

2.4.2 Global Hirudin Revenue Forecast by Region (2026-2031)

2.4.3 Global Hirudin Revenue Market Share by Region (2020-2031)

3 Market Segments

3.1 Breakdown Data by Type

3.1.1 Global Hirudin Sales by Type (2020-2031)

3.1.1.1 Global Hirudin Sales Volume by Type (2020-2031)

3.1.1.2 Global Hirudin Sales Market Share by Type (2020-2031)

3.1.2 Global Hirudin Revenue by Type (2020-2031)

3.1.2.1 Global Hirudin Revenue by Type (2020-2031)

3.1.2.2 Global Hirudin Revenue Market Share by Type (2020-2031)

3.1.3 Hirudin Average Selling Price (ASP) by Type (2020-2031)

3.2 Breakdown Data by Application

3.2.1 Global Hirudin Sales by Application (2020-2031)

3.2.1.1 Global Hirudin Sales Volume by Application (2020-2031)

3.2.1.2 Global Hirudin Sales Market Share by Application (2020-2031)

3.2.2 Global Hirudin Revenue by Application (2020-2031)

3.2.2.1 Global Hirudin Revenue by Application (2020-2031)

3.2.2.2 Global Hirudin Revenue Market Share by Application (2020-2031)

3.2.3 Hirudin Average Selling Price (ASP) by Application (2020-2031)

3.3 by Type and by Application Crossing Analysis

3.3.1 Natural Hirudin of Hirudin Revenue Market Share by Application

3.3.2 Recombinant Hirudin of Hirudin Revenue Market Share by Application

4 Global Hirudin by Manufacturers

4.1 Global Top Hirudin Manufacturers by Sales (2020-2025)

4.1.1 Global Hirudin Sales by Manufacturer (2020-2025)

4.1.2 Global Hirudin Sales Market Share by Manufacturer (2020-2025)

4.2 Global Top Hirudin Manufacturers by Revenue (2020-2025)

4.2.1 Global Hirudin Revenue by Manufacturer (2020-2025)

4.2.2 Global Hirudin Revenue Share by Manufacturer (2020-2025)

4.3 Global Hirudin Price by Manufacturer (2020-2025)

4.4 Competitive Landscape

4.4.1 Key Hirudin Manufacturers Covered: Ranking by Revenue

4.4.2 Global Hirudin Market Concentration Ratio (CR5 and HHI) & (2020-2025)

4.4.3 Global Hirudin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.5 Global Hirudin Manufacturing Base Distribution, Product Type

4.5.1 Hirudin Manufacturers Manufacturing Base Distribution, Headquarters

4.5.2 Date of International Manufacturers Enter into Hirudin Market

4.5.3 Manufacturers Hirudin Product Type and Application

4.5.4 Natural Hirudin Market Sales of Hirudin by Manufacturer

4.5.5 Recombinant Hirudin Market Sales of Hirudin by Manufacturer

4.6 Manufacturers Mergers & Acquisitions, Expansion Plans

5 Company Profiles

5.1 The Medicines Company

5.1.1 The Medicines Company Company Information

5.1.2 The Medicines Company Description, Business Overview

5.1.3 The Medicines Company Hirudin Products Offered

5.1.4 The Medicines Company Hirudin Sales, Revenue and Gross Margin (2020-2025)

5.1.5 The Medicines Company Hirudin Sales by Product in 2024

5.1.6 The Medicines Company Hirudin Sales by Application in 2024

5.1.7 The Medicines Company Hirudin Sales by Geographic Area in 2024

5.1.8 The Medicines Company Recent Developments

5.2 Keyken

5.2.1 Keyken Company Information

5.2.2 Keyken Description, Business Overview

5.2.3 Keyken Hirudin Products Offered

5.2.4 Keyken Hirudin Sales, Revenue and Gross Margin (2020-2025)

5.2.5 Keyken Hirudin Sales by Product in 2024

5.2.6 Keyken Hirudin Sales by Application in 2024

5.2.7 Keyken Hirudin Sales by Geographic Area in 2024

5.2.8 Keyken Recent Developments

5.3 Minapharm

5.3.1 Minapharm Company Information

5.3.2 Minapharm Description, Business Overview

5.3.3 Minapharm Hirudin Products Offered

5.3.4 Minapharm Hirudin Sales, Revenue and Gross Margin (2020-2025)

5.3.5 Minapharm Hirudin Sales by Product in 2024

5.3.6 Minapharm Hirudin Sales by Application in 2024

5.3.7 Minapharm Hirudin Sales by Geographic Area in 2024

5.3.8 Minapharm Recent Developments

5.4 Abbott

5.4.1 Abbott Company Information

5.4.2 Abbott Description, Business Overview

5.4.3 Abbott Hirudin Products Offered

5.4.4 Abbott Hirudin Sales, Revenue and Gross Margin (2020-2025)

5.4.5 Abbott Hirudin Sales by Product in 2024

5.4.6 Abbott Hirudin Sales by Application in 2024

5.4.7 Abbott Hirudin Sales by Geographic Area in 2024

5.4.8 Abbott Recent Developments

5.5 SALUBRIS

5.5.1 SALUBRIS Company Information

5.5.2 SALUBRIS Description, Business Overview

5.5.3 SALUBRIS Hirudin Products Offered

5.5.4 SALUBRIS Hirudin Sales, Revenue and Gross Margin (2020-2025)

5.5.5 SALUBRIS Hirudin Sales by Product in 2024

5.5.6 SALUBRIS Hirudin Sales by Application in 2024

5.5.7 SALUBRIS Hirudin Sales by Geographic Area in 2024

5.5.8 SALUBRIS Recent Developments

5.6 Pfizer, Inc

5.6.1 Pfizer, Inc Company Information

5.6.2 Pfizer, Inc Description, Business Overview

5.6.3 Pfizer, Inc Hirudin Products Offered

5.6.4 Pfizer, Inc Hirudin Sales, Revenue and Gross Margin (2020-2025)

5.6.5 Pfizer, Inc Hirudin Sales by Product in 2024

5.6.6 Pfizer, Inc Hirudin Sales by Application in 2024

5.6.7 Pfizer, Inc Hirudin Sales by Geographic Area in 2024

5.6.8 Pfizer, Inc Recent Developments

5.7 Teva Pharmaceutical Industries Ltd

5.7.1 Teva Pharmaceutical Industries Ltd Company Information

5.7.2 Teva Pharmaceutical Industries Ltd Description, Business Overview

5.7.3 Teva Pharmaceutical Industries Ltd Hirudin Products Offered

5.7.4 Teva Pharmaceutical Industries Ltd Hirudin Sales, Revenue and Gross Margin (2020-2025)

5.7.5 Teva Pharmaceutical Industries Ltd Hirudin Sales by Product in 2024

5.7.6 Teva Pharmaceutical Industries Ltd Hirudin Sales by Application in 2024

5.7.7 Teva Pharmaceutical Industries Ltd Hirudin Sales by Geographic Area in 2024

5.7.8 Teva Pharmaceutical Industries Ltd Recent Developments

5.8 DUOPUTAI

5.8.1 DUOPUTAI Company Information

5.8.2 DUOPUTAI Description, Business Overview

5.8.3 DUOPUTAI Hirudin Products Offered

5.8.4 DUOPUTAI Hirudin Sales, Revenue and Gross Margin (2020-2025)

5.8.5 DUOPUTAI Hirudin Sales by Product in 2024

5.8.6 DUOPUTAI Hirudin Sales by Application in 2024

5.8.7 DUOPUTAI Hirudin Sales by Geographic Area in 2024

5.8.8 DUOPUTAI Recent Developments

5.9 Pentapharm

5.9.1 Pentapharm Company Information

5.9.2 Pentapharm Description, Business Overview

5.9.3 Pentapharm Hirudin Products Offered

5.9.4 Pentapharm Hirudin Sales, Revenue and Gross Margin (2020-2025)

5.9.5 Pentapharm Hirudin Sales by Product in 2024

5.9.6 Pentapharm Hirudin Sales by Application in 2024

5.9.7 Pentapharm Hirudin Sales by Geographic Area in 2024

5.9.8 Pentapharm Recent Developments

6 North America

6.1 North America Hirudin Market Size YoY Growth 2020-2031

6.2 North America Hirudin Market Facts & Figures by Country

6.2.1 North America Hirudin Sales by Country (2020-2031)

6.2.2 North America Hirudin Revenue by Country (2020-2031)

6.3 North America Hirudin Sales by Type (2020-2025)

6.4 North America Hirudin Sales by Application (2020-2025)

7 Asia-Pacific

7.1 Asia-Pacific Hirudin Market Size YoY Growth 2020-2031

7.2 Asia-Pacific Hirudin Market Facts & Figures by Region

7.2.1 Asia-Pacific Hirudin Sales by Region (2020-2031)

7.2.2 Asia-Pacific Hirudin Revenue by Region (2020-2031)

7.3 Asia-Pacific Hirudin Sales by Type (2020-2025)

7.4 Asia-Pacific Hirudin Sales by Application (2020-2025)

8 Europe

8.1 Europe Hirudin Market Size YoY Growth 2020-2031

8.2 Europe Hirudin Market Facts & Figures by Country

8.2.1 Europe Hirudin Sales by Country (2020-2031)

8.2.2 Europe Hirudin Revenue by Country (2020-2031)

8.3 Europe Hirudin Sales by Type (2020-2025)

8.4 Europe Hirudin Sales by Application (2020-2025)

9 Latin America

9.1 Latin America Hirudin Market Size YoY Growth 2020-2031

9.2 Latin America Hirudin Market Facts & Figures by Country

9.2.1 Latin America Hirudin Sales by Country (2020-2031)

9.2.2 Latin America Hirudin Revenue by Country (2020-2031)

9.3 Latin America Hirudin Sales by Type (2020-2025)

9.4 Latin America Hirudin Sales by Application (2020-2025)

10 Middle East and Africa

10.1 Latin America Hirudin Market Size YoY Growth 2020-2031

10.2 Middle East and Africa Hirudin Market Facts & Figures by Country

10.2.1 Middle East and Africa Hirudin Sales by Country (2020-2031)

10.2.2 Middle East and Africa Hirudin Revenue by Country (2020-2031)

10.3 Middle East and Africa Hirudin Sales by Type (2020-2025)

10.4 Middle East and Africa Hirudin Sales by Application (2020-2025)

11 Supply Chain and Sales Channel analysis

11.1 Hirudin Supply Chain Analysis

11.2 Hirudin Key Raw Materials and Upstream Suppliers

11.3 Hirudin Clients Analysis

11.4 Hirudin Sales Channel and Sales Model Analysis

11.4.1 Hirudin Distribution Channel Analysis: Indirect Sales VS Direct Sales

11.4.2 Hirudin Distribution Channel Analysis: Online Sales VS Offline Sales

11.4.3 Hirudin Distributors

12 Hirudin Market Dynamics

12.1 Hirudin Industry Trends

12.2 Hirudin Market Drivers

12.3 Hirudin Market Challenges

12.4 Hirudin Market Restraints

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.1.1 Research Programs/Design

14.1.1.2 Market Size Estimation

14.1.1.3 Market Breakdown and Data Triangulation

14.1.2 Data Source

14.1.2.1 Secondary Sources

14.1.2.2 Primary Sources

14.2 Author Details

14.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Hirudin Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global Hirudin Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Hirudin Market Size by Region (US$ Million): 2024 VS 2031

Table 4. Global Hirudin Sales by Region (2020-2025) & (K MT)

Table 5. Global Hirudin Sales Forecast by Region (2026-2031) & (K MT)

Table 6. Global Hirudin Revenue by Region (2020-2025) & (US$ Million)

Table 7. Global Hirudin Revenue Forecast by Region (2026-2031) & (US$ Million)

Table 8. Global Hirudin Sales Volume by Type (2020-2025) & (K MT)

Table 9. Global Hirudin Sales Volume by Type (2026-2031) & (K MT)

Table 10. Global Hirudin Revenue by Type (2020-2025) & (US$ Million)

Table 11. Global Hirudin Revenue Forecast by Type (2026-2031) & (US$ Million)

Table 12. Global Hirudin Sales Volume by Application (2020-2025) & (K MT)

Table 13. Global Hirudin Sales Volume by Application (2026-2031) & (K MT)

Table 14. Global Hirudin Revenue by Application (2020-2025) & (US$ Million)

Table 15. Global Hirudin Revenue by Application (2026-2031) & (US$ Million)

Table 16. Global Hirudin Sales by Manufacturer (2020-2025) & (K MT)

Table 17. Global Hirudin Sales Share by Manufacturer (2020-2025)

Table 18. Hirudin Revenue by Manufacturer (2020-2025) & (US$ Million)

Table 19. Hirudin Revenue Share by Manufacturer (2020-2025)

Table 20. Key Manufacturers Hirudin Price (2020-2025) & (USD/MT)

Table 21. Ranking of Global Top Hirudin Manufacturers by Revenue (US$ Million) in 2024

Table 22. Global Hirudin Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)

Table 23. Global Hirudin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hirudin as of 2024)

Table 24. Hirudin Manufacturers Manufacturing Base Distribution and Headquarters

Table 25. Date of International Manufacturers Enter into Hirudin Market

Table 26. Manufacturers Hirudin Product Type and Application

Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 28. The Medicines Company Company Information

Table 29. The Medicines Company Description and Business Overview

Table 30. The Medicines Company Hirudin Product

Table 31. The Medicines Company Hirudin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 32. The Medicines Company Sales Proportion of Hirudin by Product in 2024

Table 33. The Medicines Company Sales Proportion of Hirudin by Application in 2024

Table 34. The Medicines Company Sales Proportion of Hirudin by Geographic Area in 2024

Table 35. The Medicines Company Recent Developments

Table 36. Keyken Company Information

Table 37. Keyken Description and Business Overview

Table 38. Keyken Hirudin Product

Table 39. Keyken Hirudin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 40. Keyken Sales Proportion of Hirudin by Product in 2024

Table 41. Keyken Sales Proportion of Hirudin by Application in 2024

Table 42. Keyken Sales Proportion of Hirudin by Geographic Area in 2024

Table 43. Keyken Recent Developments

Table 44. Minapharm Company Information

Table 45. Minapharm Description and Business Overview

Table 46. Minapharm Hirudin Product

Table 47. Minapharm Hirudin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 48. Minapharm Sales Proportion of Hirudin by Product in 2024

Table 49. Minapharm Sales Proportion of Hirudin by Application in 2024

Table 50. Minapharm Sales Proportion of Hirudin by Geographic Area in 2024

Table 51. Minapharm Recent Developments

Table 52. Abbott Company Information

Table 53. Abbott Description and Business Overview

Table 54. Abbott Hirudin Product

Table 55. Abbott Hirudin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 56. Abbott Sales Proportion of Hirudin by Product in 2024

Table 57. Abbott Sales Proportion of Hirudin by Application in 2024

Table 58. Abbott Sales Proportion of Hirudin by Geographic Area in 2024

Table 59. Abbott Recent Developments

Table 60. SALUBRIS Company Information

Table 61. SALUBRIS Description and Business Overview

Table 62. SALUBRIS Hirudin Product

Table 63. SALUBRIS Hirudin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 64. SALUBRIS Sales Proportion of Hirudin by Product in 2024

Table 65. SALUBRIS Sales Proportion of Hirudin by Application in 2024

Table 66. SALUBRIS Sales Proportion of Hirudin by Geographic Area in 2024

Table 67. SALUBRIS Recent Developments

Table 68. Pfizer, Inc Company Information

Table 69. Pfizer, Inc Description and Business Overview

Table 70. Pfizer, Inc Hirudin Product

Table 71. Pfizer, Inc Hirudin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 72. Pfizer, Inc Sales Proportion of Hirudin by Product in 2024

Table 73. Pfizer, Inc Sales Proportion of Hirudin by Application in 2024

Table 74. Pfizer, Inc Sales Proportion of Hirudin by Geographic Area in 2024

Table 75. Pfizer, Inc Recent Developments

Table 76. Teva Pharmaceutical Industries Ltd Company Information

Table 77. Teva Pharmaceutical Industries Ltd Description and Business Overview

Table 78. Teva Pharmaceutical Industries Ltd Hirudin Product

Table 79. Teva Pharmaceutical Industries Ltd Hirudin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 80. Teva Pharmaceutical Industries Ltd Sales Proportion of Hirudin by Product in 2024

Table 81. Teva Pharmaceutical Industries Ltd Sales Proportion of Hirudin by Application in 2024

Table 82. Teva Pharmaceutical Industries Ltd Sales Proportion of Hirudin by Geographic Area in 2024

Table 83. Teva Pharmaceutical Industries Ltd Recent Developments

Table 84. DUOPUTAI Company Information

Table 85. DUOPUTAI Description and Business Overview

Table 86. DUOPUTAI Hirudin Product

Table 87. DUOPUTAI Hirudin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 88. DUOPUTAI Sales Proportion of Hirudin by Product in 2024

Table 89. DUOPUTAI Sales Proportion of Hirudin by Application in 2024

Table 90. DUOPUTAI Sales Proportion of Hirudin by Geographic Area in 2024

Table 91. DUOPUTAI Recent Developments

Table 92. Pentapharm Company Information

Table 93. Pentapharm Description and Business Overview

Table 94. Pentapharm Hirudin Product

Table 95. Pentapharm Hirudin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 96. Pentapharm Sales Proportion of Hirudin by Product in 2024

Table 97. Pentapharm Sales Proportion of Hirudin by Application in 2024

Table 98. Pentapharm Sales Proportion of Hirudin by Geographic Area in 2024

Table 99. Pentapharm Recent Developments

Table 100. North America Hirudin Sales by Country (2020-2025) & (K MT)

Table 101. North America Hirudin Sales by Country (2026-2031) & (K MT)

Table 102. North America Hirudin Revenue by Country (2020-2025) & (US$ Million)

Table 103. North America Hirudin Revenue by Country (2026-2031) & (US$ Million)

Table 104. North America Hirudin Sales by Type (2020-2025) & (K MT)

Table 105. North America Hirudin Sales by Application (2020-2025) & (K MT)

Table 106. Asia-Pacific Hirudin Sales by Region (2020-2025) & (K MT)

Table 107. Asia-Pacific Hirudin Sales by Region (2026-2031) & (K MT)

Table 108. Asia-Pacific Hirudin Revenue by Region (2020-2025) & (US$ Million)

Table 109. Asia-Pacific Hirudin Revenue by Region (2026-2031) & (US$ Million)

Table 110. Asia-Pacific Hirudin Sales by Type (2020-2025) & (K MT)

Table 111. Asia-Pacific Hirudin Sales by Application (2020-2025) & (K MT)

Table 112. Europe Hirudin Sales by Country (2020-2025) & (K MT)

Table 113. Europe Hirudin Sales by Country (2026-2031) & (K MT)

Table 114. Europe Hirudin Revenue by Country (2020-2025) & (US$ Million)

Table 115. Europe Hirudin Revenue by Country (2026-2031) & (US$ Million)

Table 116. Europe Hirudin Sales by Type (2020-2025) & (K MT)

Table 117. Europe Hirudin Sales by Application (2020-2025) & (K MT)

Table 118. Latin America Hirudin Sales by Country (2020-2025) & (K MT)

Table 119. Latin America Hirudin Sales by Country (2026-2031) & (K MT)

Table 120. Latin America Hirudin Revenue by Country (2020-2025) & (US$ Million)

Table 121. Latin America Hirudin Revenue by Country (2026-2031) & (US$ Million)

Table 122. Latin America Hirudin Sales by Type (2020-2025) & (K MT)

Table 123. Latin America Hirudin Sales by Application (2020-2025) & (K MT)

Table 124. Middle East and Africa Hirudin Sales by Country (2020-2025) & (K MT)

Table 125. Middle East and Africa Hirudin Sales by Country (2026-2031) & (K MT)

Table 126. Middle East and Africa Hirudin Revenue by Country (2020-2025) & (US$ Million)

Table 127. Middle East and Africa Hirudin Revenue by Country (2026-2031) & (US$ Million)

Table 128. Middle East and Africa Hirudin Sales by Type (2020-2025) & (K MT)

Table 129. Middle East and Africa Hirudin Sales by Application (2020-2025) & (K MT)

Table 130. Hirudin Key Raw Materials, Industry Status and Trend

Table 131. Hirudin Key Raw Materials and Upstream Suppliers

Table 132. Hirudin Clients Status and Trend

Table 133. Hirudin Typical Clients

Table 134. Hirudin Distributors

Table 135. Hirudin Market Trends

Table 136. Hirudin Market Drivers

Table 137. Hirudin Market Challenges

Table 138. Hirudin Market Restraints

Table 139. Research Programs/Design for This Report

Table 140. Key Data Information from Secondary Sources

Table 141. Key Data Information from Primary Sources

Table 142. QYR Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Hirudin Product Picture

Figure 2. Global Hirudin Market Size by Type (US$ Million): 2020 VS 2024 VS 2031

Figure 3. Global Hirudin Sales Market Share by Type in 2024 & 2031

Figure 4. Natural Hirudin Product Picture

Figure 5. Recombinant Hirudin Product Picture

Figure 6. Global Hirudin Market Size by Application (US$ Million): 2020 VS 2024 VS 2031

Figure 7. Global Hirudin Sales Market Share by Application in 2024 & 2031

Figure 8. Thrombosis Disease

Figure 9. Tumor Disease

Figure 10. Others

Figure 11. Hirudin Report Years Considered

Figure 12. Global Hirudin Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Hirudin Market Size 2020-2031 (US$ Million)

Figure 14. Global Hirudin Sales 2020-2031 (K MT)

Figure 15. Global Hirudin Sales Market Share Forecast by Region (2020-2031)

Figure 16. Global Hirudin Revenue Market Share by Region (2020-2031)

Figure 17. Global Hirudin Sales Market Share Forecast by Type (2020-2031)

Figure 18. Global Hirudin Revenue Market Share Forecast by Type (2020-2031)

Figure 19. Hirudin Average Selling Price (ASP) by Type (2020-2025) & (USD/MT)

Figure 20. Global Hirudin Sales Market Share Forecast by Application (2020-2031)

Figure 21. Global Hirudin Revenue Market Share Forecast by Application (2020-2031)

Figure 22. Hirudin Average Selling Price (ASP) by Application (2020-2025) & (USD/MT)

Figure 23. Natural Hirudin of Hirudin Revenue Market Share by Application, 2024 VS 2031

Figure 24. Recombinant Hirudin of Hirudin Revenue Market Share by Application, 2024 VS 2031

Figure 25. Global Hirudin Sales Share by Manufacturer in 2024

Figure 26. Hirudin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 27. Natural Hirudin Market Sales Proportion by Manufacturer in 2024

Figure 28. Recombinant Hirudin Market Sales Proportion by Manufacturer in 2024

Figure 29. North America Hirudin Revenue 2020-2031 (US$ Million)

Figure 30. North America Hirudin Sales Market Share by Type (2020-2025)

Figure 31. North America Hirudin Sales Market Share by Application (2020-2025)

Figure 32. Asia-Pacific Hirudin Revenue 2020-2031 (US$ Million)

Figure 33. Asia-Pacific Hirudin Sales Market Share by Region (2020-2031)

Figure 34. Asia-Pacific Hirudin Revenue Market Share by Region (2020-2031)

Figure 35. Asia-Pacific Hirudin Sales Market Share by Type (2020-2025)

Figure 36. Asia-Pacific Hirudin Sales Market Share by Application (2020-2025)

Figure 37. Europe Hirudin Revenue Growth Rate 2020-2031 (US$ Million)

Figure 38. Europe Hirudin Sales Market Share by Country (2020-2031)

Figure 39. Europe Hirudin Revenue Market Share by Country (2020-2031)

Figure 40. Europe Hirudin Sales Market Share by Type (2020-2025)

Figure 41. Europe Hirudin Sales Market Share by Application (2020-2025)

Figure 42. Latin America Hirudin Revenue Growth Rate 2020-2031 (US$ Million)

Figure 43. Latin America Hirudin Sales Market Share by Country (2020-2031)

Figure 44. Latin America Hirudin Revenue Market Share by Country (2020-2025)

Figure 45. Latin America Hirudin Sales Market Share by Type (2020-2025)

Figure 46. Latin America Hirudin Sales Market Share by Application (2020-2025)

Figure 47. Middle East and Africa Hirudin Revenue Growth Rate 2020-2031 (US$ Million)

Figure 48. Middle East and Africa Hirudin Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Hirudin Revenue Market Share by Country (2020-2031)

Figure 50. Middle East and Africa Hirudin Sales Market Share by Type (2020-2025)

Figure 51. Middle East and Africa Hirudin Sales Market Share by Application (2020-2025)

Figure 52. Hirudin Supply Chain (Upstream and Downstream Market)

Figure 53. Global Production Market Share of Hirudin Raw Materials by Region in 2024

Figure 54. Hirudin Distribution Channels

Figure 55. Global Hirudin Percentage 2020-2031: Indirect Sales VS Direct Sales

Figure 56. Global Hirudin Percentage 2020-2031: Online Sales VS Offline Sales

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Hirudin market? zhanKai

The top companies in the global Hirudin market are The Medicines Company、Keyken、Minapharm.

What was the global market size of Hirudin in 2025? shouQi

What was the global market size of Hirudin in 2031? shouQi

Which region is expected to have the highest market share? shouQi

What is the annual compound growth rate of the global Hirudin market size from 2025 to 2031? shouQi

Related Reports

Global Hirudin Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hirudin market size was US$ 4341 million in 2025 and is forecast to reach a readjusted size of US$ 5359 million by 2032 with a CAGR of 3.1% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 107
USD 4250.00
(Single User License)
Global Hirudin Market Research Report 2026
The global Hirudin market was valued at US$ 4341 million in 2025 and is anticipated to reach US$ 5359 million by 2032, at a CAGR of 3.1% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 150
USD 2900.00
(Single User License)
Hirudin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hirudin was estimated to be worth US$ 4341 million in 2025 and is projected to reach US$ 5359 million, growing at a CAGR of 3.1% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 138
USD 3950.00
(Single User License)
Global Hirudin Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Hirudin market is projected to grow from US$ 4223 million in 2024 to US$ 5214 million by 2031, at a CAGR of 3.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 180
USD 4900.00
(Single User License)
Hirudin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hirudin was estimated to be worth US$ 4223 million in 2024 and is forecast to a readjusted size of US$ 5214 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-06-11
Pages: 142
USD 3950.00
(Single User License)
Global Hirudin Market Insights, Forecast to 2031
The global Hirudin market is projected to grow from US$ 4341 million in 2025 to US$ 5214 million by 2031, at a Compound Annual Growth Rate (CAGR) of 3.1% during the forecast period.
Published Date: 2025-06-11
Pages: 180
USD 4900.00
(Single User License)
Global Hirudin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hirudin market size was US$ 4223 million in 2024 and is forecast to a readjusted size of US$ 5214 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-06-11
Pages: 106
USD 4250.00
(Single User License)
Global Hirudin Market Research Report 2025
The global market for Hirudin was valued at US$ 4223 million in the year 2024 and is projected to reach a revised size of US$ 5214 million by 2031, growing at a CAGR of 3.1% during the forecast period.
Published Date: 2025-06-11
Pages: 114
USD 2900.00
(Single User License)
Hirudin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hirudin was estimated to be worth US$ 4223 million in 2024 and is forecast to a readjusted size of US$ 5214 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 97
USD 3950.00
(Single User License)
Global Hirudin Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
This report studies the Hirudin market. Hirudin is a naturally occurring peptide in the salivary glands of medicinal leeches (such as Hirudo medicinalis) that has a blood anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin. Hirudin (hirudin) is a Leech (Leech) and salivary glands have been extracted from a variety of active ingredients in the activity of the most significant and most studied ingredients, which is 65-66 amino acids from the small molecules of protein (peptide) . Hirudin have strong inhibitory effect on thrombin is the strongest so far found in the natural specific inhibitor of thrombin. Animal experiments and clinical studies have shown that hirudin can be effective anticoagulant, antithrombotic, and prevent thrombin-catalyzed activation of coagulation factors and platelet reactions and blood stasis phenomenon further. In addition, it also inhibited thrombin-induced fibroblast proliferation, and thrombin stimulation of endothelial cells. Compared with heparin, which not only use less, do not cause bleeding, is not dependent on endogenous cofactor; and heparin have caused the risk of bleeding, disseminated intravascular coagulation in the pathogenesis of antithrombin III are reduced This will limit the efficacy of heparin, using leeches will have good results.
Published Date: 2024-04-17
Pages: 154
USD 5600.00
(Single User License)

Global Hirudin Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hirudin market size was US$ 4341 million in 2025 and is forecast to reach a readjusted size of US$ 5359 million by 2032 with a CAGR of 3.1% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 107
USD 4250.00 (Single User License)
Global Hirudin Market Research Report 2026
The global Hirudin market was valued at US$ 4341 million in 2025 and is anticipated to reach US$ 5359 million by 2032, at a CAGR of 3.1% from 2026 to 2032.
Published: 2026-01-04
Pages: 150
USD 2900.00 (Single User License)
Hirudin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hirudin was estimated to be worth US$ 4341 million in 2025 and is projected to reach US$ 5359 million, growing at a CAGR of 3.1% from 2026 to 2032.
Published: 2026-01-04
Pages: 138
USD 3950.00 (Single User License)
Global Hirudin Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Hirudin market is projected to grow from US$ 4223 million in 2024 to US$ 5214 million by 2031, at a CAGR of 3.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 180
USD 4900.00 (Single User License)
Hirudin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hirudin was estimated to be worth US$ 4223 million in 2024 and is forecast to a readjusted size of US$ 5214 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-06-11
Pages: 142
USD 3950.00 (Single User License)
Global Hirudin Market Insights, Forecast to 2031
The global Hirudin market is projected to grow from US$ 4341 million in 2025 to US$ 5214 million by 2031, at a Compound Annual Growth Rate (CAGR) of 3.1% during the forecast period.
Published: 2025-06-11
Pages: 180
USD 4900.00 (Single User License)
Global Hirudin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hirudin market size was US$ 4223 million in 2024 and is forecast to a readjusted size of US$ 5214 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-06-11
Pages: 106
USD 4250.00 (Single User License)
Global Hirudin Market Research Report 2025
The global market for Hirudin was valued at US$ 4223 million in the year 2024 and is projected to reach a revised size of US$ 5214 million by 2031, growing at a CAGR of 3.1% during the forecast period.
Published: 2025-06-11
Pages: 114
USD 2900.00 (Single User License)
Hirudin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hirudin was estimated to be worth US$ 4223 million in 2024 and is forecast to a readjusted size of US$ 5214 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 97
USD 3950.00 (Single User License)
Global Hirudin Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
This report studies the Hirudin market. Hirudin is a naturally occurring peptide in the salivary glands of medicinal leeches (such as Hirudo medicinalis) that has a blood anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin. Hirudin (hirudin) is a Leech (Leech) and salivary glands have been extracted from a variety of active ingredients in the activity of the most significant and most studied ingredients, which is 65-66 amino acids from the small molecules of protein (peptide) . Hirudin have strong inhibitory effect on thrombin is the strongest so far found in the natural specific inhibitor of thrombin. Animal experiments and clinical studies have shown that hirudin can be effective anticoagulant, antithrombotic, and prevent thrombin-catalyzed activation of coagulation factors and platelet reactions and blood stasis phenomenon further. In addition, it also inhibited thrombin-induced fibroblast proliferation, and thrombin stimulation of endothelial cells. Compared with heparin, which not only use less, do not cause bleeding, is not dependent on endogenous cofactor; and heparin have caused the risk of bleeding, disseminated intravascular coagulation in the pathogenesis of antithrombin III are reduced This will limit the efficacy of heparin, using leeches will have good results.
Published: 2024-04-17
Pages: 154
USD 5600.00 (Single User License)